Back to All Events

Cambridge Healthtech Institute’s 3rd Annual AI/ML-Enabled Drug Discovery - Part 2

Predicting Proteolysis-Targeting Chimeras' (PROTACs) ADME/Tox Properties

We have tested a small set of PROTACs against several human drug transporters in vitro as well as in zebrafish for their effects on embryo and larval mortality, morphology, embryo photomotor response, and larval photomotor response. We will report the preliminary outcomes of these combined assessments and discuss the implications for PROTACs development as well as how this data could be used for machine learning model generation and evaluation.

Previous
Previous
September 25

Panel: The Business Innovation

Next
Next
October 21

Eighth International Conference on Drug Discovery and Lead Optimization